We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
PAPAVERINE PHEBRA (Phebra Pty Ltd)
Product name
PAPAVERINE PHEBRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
130 (255 working days)
Active ingredients
papaverine hydrochloride
Registration type
New generic medicine
Indication
Papaverine Phebra is indicated for the treatment of erectile dysfunction.